AG˹ٷ

STOCK TITAN

Early Expiration Price Condition for Warrants Satisfied Alternate Expiration Date Elected

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags

Enovix Corporation (Nasdaq: ENVX) announced that its warrants (ENVXW) have met the early expiration price condition, with the stock's volume-weighted average price exceeding $10.50. The company has set Friday, August 29, 2025 as the alternate expiration date for the warrants.

Warrant holders must exercise their warrants at $8.75 per warrant before 5:00 p.m. New York City time on August 29, 2025. To date, approximately 12.3 million warrants have been exercised, generating about $107.5 million in gross proceeds for Enovix. The company has implemented a Notice of Guaranteed Delivery process to accommodate warrant holders whose financial institutions may need additional processing time.

Enovix Corporation (Nasdaq: ENVX) ha comunicato che i suoi warrant (ENVXW) hanno soddisfatto la condizione di scadenza anticipata, con il prezzo medio ponderato per volume delle azioni superiore a $10,50. La società ha fissato come data alternativa di scadenza dei warrant il venerdì 29 agosto 2025.

I detentori di warrant devono esercitare i loro diritti al prezzo di $8,75 per warrant entro le ore 17:00 (ora di New York) del 29 agosto 2025. Ad oggi, circa 12,3 milioni di warrant sono stati esercitati, realizzando approssimativamente $107,5 milioni di proventi lordi per Enovix. Per agevolare i titolari i cui istituti finanziari richiedano più tempo di elaborazione, la società ha attivato una procedura di Notifica di Consegna Garantita.

Enovix Corporation (Nasdaq: ENVX) anunció que sus warrants (ENVXW) cumplieron la condición de vencimiento anticipado, con el precio medio ponderado por volumen de la acción por encima de $10.50. La compañía estableció como fecha alternativa de vencimiento de los warrants el viernes 29 de agosto de 2025.

Los tenedores de warrants deben ejercerlos a $8.75 por warrant antes de las 5:00 p.m., hora de Nueva York, del 29 de agosto de 2025. Hasta la fecha, aproximadamente 12.3 millones de warrants se han ejercido, generando alrededor de $107.5 millones en ingresos brutos para Enovix. La empresa implementó un proceso de Notificación de Entrega Garantizada para quienes necesiten más tiempo de procesamiento por parte de sus instituciones financieras.

Enovix Corporation (Nasdaq: ENVX)� 워런�(ENVXW)가 조기 만료 요건� 충족했으� 주식� 거래� 가� 평균가격이 $10.50� 초과했다� 발표했습니다. 회사� 워런트의 대� 만기일을 2025� 8� 29� 금요�� 지정했습니�.

워런� 보유자는 2025� 8� 29� 뉴욕 시간 오후 5� 이전� 워런트를 워런트당 $8.75� 행사해야 합니�. 현재까지 � 1,230� 워런트가 행사되어 Enovix� � $1� 750�� 총수익을 발생시켰습니�. 금융기관� 추가 처리 시간� 필요� 보유자를 위해 회사� 보장 전달 통지(Notice of Guaranteed Delivery) 절차� 마련했습니다.

Enovix Corporation (Nasdaq: ENVX) a annoncé que ses warrants (ENVXW) ont rempli la condition d'expiration anticipée, le prix moyen pondéré par le volume de l'action dépassant 10,50 $. La société a fixé le vendredi 29 août 2025 comme date d'échéance alternative des warrants.

Les titulaires de warrants doivent exercer leurs warrants à 8,75 $ par warrant avant 17h00, heure de New York, le 29 août 2025. À ce jour, environ 12,3 millions de warrants ont été exercés, générant environ 107,5 millions de dollars de produits bruts pour Enovix. La société a mis en place une procédure de Notification de Livraison Garantie pour les titulaires dont les établissements financiers pourraient nécessiter un délai de traitement supplémentaire.

Enovix Corporation (Nasdaq: ENVX) gab bekannt, dass ihre Warrants (ENVXW) die Bedingung für eine vorzeitige Fälligkeit erfüllt haben, da der volumen­gewichtete Durchschnittskurs der Aktie über $10,50 liegt. Das Unternehmen hat den Freitag, 29. August 2025 als alternativen Verfallstag der Warrants festgelegt.

Warrant-Inhaber müssen ihre Warrants zu $8,75 pro Warrant bis spätestens 17:00 Uhr New Yorker Zeit am 29. August 2025 ausüben. Bislang wurden rund 12,3 Millionen Warrants ausgeübt, wodurch Enovix etwa $107,5 Millionen Bruttoerlös erzielt hat. Um Inhabern, deren Finanzinstitute zusätzliche Bearbeitungszeit benötigen, entgegenzukommen, hat das Unternehmen ein Verfahren zur Notice of Guaranteed Delivery eingerichtet.

Positive
  • None.
Negative
  • Remaining unexercised warrants will become void after expiration date
  • Short timeline for remaining warrant holders to exercise (deadline August 29, 2025)

Insights

Enovix raises $107.5M from warrant exercises with early expiration triggered, strengthening their balance sheet for production scaling.

Enovix Corporation has successfully triggered the early expiration condition for its publicly traded warrants by maintaining a volume-weighted average stock price above $10.50 for the required trading period. This has established August 29, 2025, as the alternate expiration date for all remaining warrants, provided the stock maintains a VWAP of at least $8.75 through the expiration date.

The financial implications are substantial. Approximately 12.3 million warrants have already been exercised, generating $107.5 million in gross proceeds for Enovix, with additional proceeds expected as remaining warrant holders exercise before expiration. Each warrant allows the purchase of one share of common stock at $8.75 per warrant.

This warrant exercise represents a significant non-dilutive capital infusion compared to traditional equity raises. The $1.75+ premium between the $8.75 exercise price and the $10.50 VWAP threshold indicates the market's positive valuation of Enovix shares, effectively validating investor confidence in the company's silicon-anode battery technology.

Management has strategically positioned this capital influx to support production scaling initiatives. CEO Raj Talluri specifically connected this milestone to their AI-1� battery achievements, suggesting the proceeds will accelerate commercialization of their silicon-anode technology. CFO Ryan Benton's comments indicate these funds will support their transition toward profitability.

For remaining warrant holders, the company has implemented accommodative measures including a Notice of Guaranteed Delivery process to facilitate timely exercises before the rapidly approaching deadline. After 5:00 p.m. on August 29, unexercised warrants become void, creating urgency for holder action.

Warrants Must be Exercised Prior to 5:00 p.m. New York City Time on Friday, August 29, 2025

Last Day of Warrant Trading on Nasdaq is Friday, August 29, 2025

Notice of Guaranteed Delivery is Available for Warrant Exercises

12.3 Million Warrants Already Exercised for Approximately $107.5 Million Gross Proceeds

FREMONT, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX, ENVXW) (“Company� or “Enovix�), a leader in advanced silicon battery technology, announced that on August 27, 2025, the volume-weighted average price (“VWAP�) of its common stock had exceeded $10.50 for the requisite number of trading days since the distribution of the Company warrants currently traded on Nasdaq under ENVXW (the “Warrants�) to satisfy the early expiration price condition applicable to the Warrants in accordance with the Warrant Agreement, dated as of July 21, 2025, between Enovix and Computershare Trust Company N.A., as Warrant Agent (the “Warrant Agreement�). Pursuant to the Warrant Agreement, the Company has elected to set Friday, August 29, 2025 as the alternate expiration date for the Warrants.

As a result, the Warrants will stop trading on Nasdaq at 4:00 p.m. New York City time on August 29, 2025, and the Warrants must be exercised prior to 5:00 p.m. New York City time on August 29, 2025, in each case, as long as the VWAP of the Company’s common stock is at least $8.75 for each of the two trading days immediately preceding such expiration date (the “Additional Price Condition�). The Company will issue an additional press release to confirm whether the Additional Price Condition has been satisfied, and to reconfirm the final trading day and expiration date of the Warrants.

Each Warrant may be cash exercised to purchase one share of the Company’s common stock prior to 5:00 p.m. New York City time on August 29, 2025 for an exercise price of $8.75 per Warrant. As of August 26, 2025, approximately 12.3 million Warrants have already been exercised, generating approximately $107.5 million in gross proceeds for the Company to date, with further proceeds expected as Warrants are exercised prior to their expiration.

Raj Talluri, President and Chief Executive Officer of Enovix, stated “Reaching the early expiration trigger on our warrant dividend is a strong validation of shareholder confidence in Enovix. Combined with independent testing confirming the AI-1� battery as the highest energy density smartphone cell available, this milestone highlights the momentum behind our breakthrough battery technology. Warrant exercise proceeds strengthen our ability to scale production of our 100% silicon-anode technology to meet growing customer demand.�

Ryan Benton, Chief Financial Officer of Enovix, added, “From the outset, our goal was to design a program that created real value for our shareholders. I’m proud of how our team executed to achieve this milestone and grateful for the confidence and support from our investors. This achievement strengthens Enovix as we ramp up production and commercialization activities across the company and build the foundation for durable, profitable growth.�

From and after 5:00 p.m. New York City time on August 29, 2025, the Warrants will no longer be exercisable and will be void, and the holders of unexercised Warrants will have no further rights with respect to any Warrants. We encourage all Warrant holders to ensure their Warrants are traded or exercised on a timely basis prior to the deadlines above. Processing procedures and timelines may vary by broker or the institution holding your Warrants, so prompt action is recommended.

As an accommodation to Warrant holders, the Company has instituted a process by which Warrant holders may cash-exercise their Warrants using a Notice of Guaranteed Delivery for Exercise of Warrants (the “Notice�). The Company is offering Warrant holders the opportunity to use the Notice if the procedures used by a financial institution for the exercise of Warrants cannot be completed by that financial institution on a timely basis before 5:00 p.m. New York City time on August 29, 2025. It is important to note that Warrant holders who wish to cash-exercise their Warrants must submit the Notice and the payment of the $8.75 per Warrant exercise price before 5:00 p.m. New York City time on August 29, 2025. Please refer to the Notice itself for detailed information regarding its use. Additionally, the Company, in its discretion, may elect to accommodate exercises that were submitted in good faith in accordance with the Warrant Agreement prior to 5:00 p.m. New York City time on August 29, 2025. A full copy of the Notice is attached as Exhibit 99.2 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission (“SEC�) on August 28, 2025, and is available on the Company’s website at https://www.enovix.com/enovix-warrant-dividend.

Further Information Relating to the Warrants

For more information relating to the exercise mechanics and other terms of the Warrants, please refer to the materials filed by the Company with the SEC available at https://www.sec.gov and the information posted on the Company’s website at https://www.enovix.com/enovix-warrant-dividend.

About Enovix Corporation

Enovix is a leader in advancing lithium-ion battery technology with its proprietary cell architecture designed to deliver higher energy density and improved safety. The Company’s breakthrough silicon-anode batteries are engineered to power a wide range of devices from wearable electronics and mobile communications to industrial and electric vehicle applications. Enovix’s technology enables longer battery life and faster charging, supporting the growing global demand for high-performance energy storage. Enovix holds a robust portfolio of issued and pending patents covering its core battery design and manufacturing process.

Enovix is headquartered in Silicon Valley with facilities in India, South Korea and Malaysia. For more information visit  and follow us on .

No Offer or Solicitation

This press release is for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The issuance of the Warrants has not been registered under the Securities Act of 1933, as amended (the “Securities Act�), as the distribution of a Warrant for no consideration does not constitute a sale of a security under Section 2(a)(3) of the Securities Act. A Form 8-A registration statement and prospectus supplement describing the terms of the Warrants were filed with the SEC and are available on the SEC’s website located at https://www.sec.gov. Holders of Warrants should read the prospectus supplement carefully, including the Risk Factors section included and incorporated by reference therein. This press release contains a general summary of certain terms applicable to the Warrants. Please read the Warrant Agreement filed as an exhibit to the Company’s Current Report on Form 8-K filed with the SEC on July 21, 2025 as it contains important information about the terms of the Warrants.

Forward‐Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, about us, the Warrants and our business that involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance and can be identified by words such as anticipate, believe, continue, could, estimate, expect, intend, may, might, plan, possible, potential, predict, should, would and similar expressions that convey uncertainty about future events or outcomes. Forward-looking statements in this press release include, without limitation, the expected satisfaction of the Additional Price Condition, the currently anticipated alternate expiration date of the Warrants, the impact of the Warrant exercise proceeds on the Company’s ability to scale production and commercialization activities and build the foundation for profitable growth, our ability to accommodate good faith warrant exercises, the total warrant exercise proceeds and matters relating to the Notice. Actual results and outcomes could differ materially from these forward-looking statements as a result of certain risks and uncertainties, including, without limitation, those risks and uncertainties and other potential factors set forth in our filings with the SEC, including in the “Risk Factors� and “Management’s Discussion and Analysis of Financial Condition and Results of Operations� sections of our most recently filed annual report on Form 10-K and quarterly reports on Form 10-Q and other documents that we have filed, or that we will file, with the SEC. For a full discussion of these risks, please refer to Enovix’s filings with the SEC, including its most recent Form 10-K and Form 10-Q, available at https://ir.enovix.com and www.sec.gov. Any forward-looking statements made by us in this press release speak only as of the date on which they are made and subsequent events may cause these expectations to change. We disclaim any obligations to update or alter these forward-looking statements in the future, whether as a result of new information, future events or otherwise, except as required by law.

Investor Contact:
Robert Lahey
[email protected]

Chief Financial Officer:
Ryan Benton
[email protected]


FAQ

When do Enovix (ENVX) warrants expire?

Enovix warrants (ENVXW) must be exercised by 5:00 p.m. New York City time on Friday, August 29, 2025. The last trading day on Nasdaq is also August 29, 2025.

What is the exercise price for Enovix warrants?

Each Enovix warrant can be exercised to purchase one share of common stock for $8.75 per warrant.

How much has Enovix raised from warrant exercises so far?

Enovix has generated approximately $107.5 million in gross proceeds from about 12.3 million warrants exercised to date.

What happens to unexercised Enovix warrants after the expiration date?

After 5:00 p.m. New York City time on August 29, 2025, any unexercised warrants will become void and holders will have no further rights with respect to them.

How can Enovix warrant holders exercise their warrants before expiration?

Warrant holders can either exercise through their broker or use the Notice of Guaranteed Delivery process if their financial institution needs additional processing time. Both the notice and the $8.75 per warrant payment must be submitted by the August 29 deadline.
Enovix Corporation

NASDAQ:ENVX

ENVX Rankings

ENVX Latest News

ENVX Latest SEC Filings

ENVX Stock Data

2.05B
171.44M
12.8%
46.66%
21.85%
Electrical Equipment & Parts
Miscellaneous Electrical Machinery, Equipment & Supplies
United States
FREMONT